Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Phase 1/2 Clinical Study of VRDN-001, A Full Antagonist Antibody to the Insulin-Like Growth Factor-1 Receptor (IGF-1R), in Patients with Thyroid Eye Disease (TED)

              Author:Moster, Mark   Douglas, Raymond   Cockerham, Kimberly   Turbin, Roger   Nijhawan, Navdeep   Schiffman, Jade   Ugradar, Shoaib   O'Shaughnessy, Denis   Summerfelt, Rochelle   She, Angela   Katz, Barrett   

              Session Name:P3: Neuro-ophthalmology/Neuro-otology: Clinical Research of the Efferent Visual System  

              Topic:Neuro-ophthalmology/Neuro-otology  

              Program Number:P3.001  

              Author Institution:Neuro-Ophthalmology-Wills Eye Hospital, Philadelphia, PA  Cedars Sinai Medical Center, Los Angeles, CA  University of California San Francisco, San Francisco, CA  Rutgers-New Jersey Medical School/Dept of Ophthalmology, Newark, NJ  Oshawa Clinic, Ontario, ON, Canada  Neuroeye Diagnostic PA, Houston, TX  The UCLA Stein Eye Institute, Los Angeles, CA  Viridian Therapeutics Inc., Waltham, MA  Viridian Therapeutics Inc., Waltham, CA  Viridian Therapeutics Inc., Cuthogue, NY